{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:04:51Z","timestamp":1792613091958,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.avsg.2026.03.010","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:42:29Z","timestamp":1774658549000},"page":"404-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The Combined Effect of Renin Angiotensin System Blockade and Metformin on Abdominal Aortic Aneurysm Growth Rate in People with Diabetes Mellitus\u2014A Propensity-Matched Retrospective Cohort Study"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4042-0515","authenticated-orcid":false,"given":"E.A.A.A.","family":"Otify","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Nunney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Dhatariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.W.","family":"Stather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2026.03.010_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10654-019-00510-9","article-title":"Blood pressure, hypertension and the risk of abdominal aortic aneurysms: a systematic review and meta-analysis of cohort studies","volume":"34","author":"Kobeissi","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.avsg.2026.03.010_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.721213","article-title":"The protective effect of metformin on abdominal aortic aneurysm: a systematic review and meta-analysis","volume":"12","author":"Yuan","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.avsg.2026.03.010_bib4","author":"Dalman"},{"key":"10.1016\/j.avsg.2026.03.010_bib5","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI7818","article-title":"Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice","volume":"105","author":"Daugherty","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.avsg.2026.03.010_bib6","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ijcard.2012.10.007","article-title":"The past, present and future of renin\u2013angiotensin aldosterone system inhibition","volume":"167","author":"Mentz","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.avsg.2026.03.010_bib7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1476-5381.2010.00750.x","article-title":"Renin\u2013angiotensin\u2013aldosterone system blockade for cardiovascular diseases: current status","volume":"160","author":"Ma","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.avsg.2026.03.010_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/CS20120097","article-title":"Involvement of the renin\u2013angiotensin system in abdominal and thoracic aortic aneurysms","volume":"123","author":"Lu","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.avsg.2026.03.010_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(06)69250-7","article-title":"Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study","volume":"368","author":"Hackam","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2026.03.010_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jvs.2010.02.012","article-title":"An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance","volume":"52","author":"Thompson","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.03.010_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvs.2010.02.264","article-title":"Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms","volume":"52","author":"Sweeting","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.03.010_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.2011.06332.x","article-title":"Relevance of angiotensin II-induced aortic pathologies in mice to human aortic aneurysms","volume":"1245","author":"Bruemmer","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.avsg.2026.03.010_bib13","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0741-5214(02)00139-8","article-title":"An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents beta-aminopropionitrile monofumarate-induced aortic dissection in rats","volume":"36","author":"Nagashima","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.03.010_bib14","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/heartjnl-2014-305648","article-title":"Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies","volume":"100","author":"Davis","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.avsg.2026.03.010_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.avsg.2020.06.039","article-title":"Metformin prescription associated with reduced abdominal aortic aneurysm growth rate and reduced chemokine expression in a Swedish cohort","volume":"70","author":"Unosson","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2026.03.010_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jvs.2016.02.020","article-title":"Metformin treatment status and abdominal aortic aneurysm disease progression","volume":"64","author":"Fujimura","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.03.010_bib18","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1186\/s13063-021-05915-0","article-title":"Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm","volume":"22","author":"Golledge","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.avsg.2026.03.010_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cmet.2012.11.012","article-title":"Vascular complications of diabetes: mechanisms of injury and protective factors","volume":"17","author":"Rask-Madsen","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.avsg.2026.03.010_bib20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1524-6175.2002.01641.x","article-title":"ACE inhibitors and protection against kidney disease progression in patients with type 2 diabetes: what's the evidence","volume":"4","author":"Bakris","year":"2002","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.avsg.2026.03.010_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20590","article-title":"An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo-controlled trial (AARDVARK)","volume":"20","author":"Kiru","year":"2016","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.avsg.2026.03.010_bib22","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/ATVBAHA.116.308874","article-title":"Glycated hemoglobin is associated with the growth rate of abdominal aortic aneurysms: a substudy from the VIVA (Viborg vascular) randomized screening trial","volume":"37","author":"Kristensen","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2026.03.010_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/14017431.2017.1319971","article-title":"Aortic diameter at age 65 in men with newly diagnosed type 2 diabetes","volume":"51","author":"Taimour","year":"2017","journal-title":"Sc Cardiovasc J"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509626001718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509626001718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:09:33Z","timestamp":1792066173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509626001718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":21,"alternative-id":["S0890509626001718"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2026.03.010","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Combined Effect of Renin Angiotensin System Blockade and Metformin on Abdominal Aortic Aneurysm Growth Rate in People with Diabetes Mellitus\u2014A Propensity-Matched Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2026.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}